Traditional chemotherapeutic agents act by killing cells that dividing rapidly, a critical equity of most cancer cells. They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone uncontrolled growth and will often form a mass, but may be dispersed diffusely.
Precision medicine is an access to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic considerate for their disease. This may also be called illustrate medicine
Cancer is the most leading disease cause of death worldwide and in all places of the world. The prevalence of all cancers is predicted to 22% increases by 2011-2030, mainly due to ageing and also possibly due to increase to risk factors for cancer. Breast cancer is the most common causing cancer in females, prostate cancer, prostate cancer, blood cancer, lung cancer and bowel cancers are the common cancers among males but are immensely rare in a female, which follow the prevalence of smoking (24.0% vs. 0.7%, respectively).
cancer is the third most commonly diagnosed cancer and the also leading disease cause of death in females worldwide, accounting for 10% (530,800) of the total new cancer cases and 9% (278,100) of the total cancer deaths among females. More than 87% of these cases and deaths occur in developing countries. And also lung cancer is the one of the most destructive tumors and survival after 5-6 years is very low: only 12% of patients diagnosed with a malignant neoplasm survive for more than five years.
Ovarian cancer is very varied diagnosis depending on age: Nearly 72% of the group between 15 and 44 years survives this form of cancer; this is the case for only 20% of those over 75years-old.
The recent improvement in the cancer treatments & cancer care is accelerating. A cluster of innovative treatments, often connected with other new or extant medicines, and regularly associated with biomarkers, are developing from the research and development pipeline. Over the past five years, 70-75 new cancer treatments have been started and are being used to treat over 20-25 different types of tumors. The global cancer biomarker market size was worth at USD 11 billion in the year 2017 and is estimated to reach a value of USD 35.7 billion by 2025, growing with CAGR of 16%.
Academicians, healthcare professionals, oncologists, radiologists, academicians, chemotherapists, professors, cancer professionals, physicians, breast cancer surgeons, pathologists, medical practitioners, diagnostic laboratory professionals, genetic scientists, students, industry professionals
cancer diagnosis and cancer therapy conferences| cancer therapy conferences 2019|cancer therapy radiation| chemotherapy for cancer| cancer therapy conferences Miami| cancer research therapy 2019| cancer research USA| cancer therapy radiation 2019| cancer research 2019
Crowne plaza, 950 NW 42nd Ave, Miami, FL 33126, USA